2004
DOI: 10.1111/j.1525-1594.2004.07321.x
|View full text |Cite
|
Sign up to set email alerts
|

Cell‐based Therapy to Regenerate Myocardium: from Bench to Bedside

Abstract: The field of cell-based therapy to regenerate myocardium has been expanding rapidly, with significant advances being made in both the laboratory and the clinical area. In this article we review this field, including our experiences and discuss remaining issues and possibilities for future clinical applications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2005
2005
2006
2006

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…However, poor graftability due to vessel quality is associated with a decrease in both survival and freedom from angina (50,51). Therapeutic angiogenesis can be effectively induced by cell‐based therapies (52).…”
Section: Clinical Indications Of Cell‐based Therapiesmentioning
confidence: 99%
“…However, poor graftability due to vessel quality is associated with a decrease in both survival and freedom from angina (50,51). Therapeutic angiogenesis can be effectively induced by cell‐based therapies (52).…”
Section: Clinical Indications Of Cell‐based Therapiesmentioning
confidence: 99%
“…Shinji Tomita (127) of the Green Lane Hospital (Auckland, New Zealand) reviewed the field of cell‐based therapy to regenerate myocardium. Cell‐based therapy will continue to expand.…”
Section: Tissue Engineeringmentioning
confidence: 99%